Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey

S.K. Mahil, M. Yates, S.M. Langan, Z.Z.N. Yiu, T. Tsakok, N. Dand, K.J. Mason, H. Mcateer, F. Meynell, B. Coker, A. Vincent, D. Urmston, A. Vesty, J. Kelly, C. Lancelot, L. Moorhead, H. Bachelez, I.n. Bruce, F. Capon, C.r. ContrerasA.P. Cope, C. De la cruz, P. Di Meglio, P. Gisondi, K. Hyrich, D. Jullien, J. Lambert, H. Marzo‐ortega, I. Mcinnes, L. Naldi, S. Norton, L. Puig, R. Sengupta, P. Spuls, T. Torres, R.b. Warren, H. Waweru, J. Weinman, C.e.m. Griffiths, J.n. Barker, M.a. Brown, J.B. Galloway, C.H. Smith

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science